8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Published . Updated .
Key takeaways
- 8-K - ONCOLYTICS BIOTECH filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
- Exposed: ONCY
- Market reaction: ONCY +12.9% after two sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - ONCOLYTICS BIOTECH filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- ONCY Oncolytics Biotech-10.8% 19d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “biotech” (pharma and health) in this story.
- LLY Eli Lilly and+14.3% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- PFE Pfizer+2.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
- MRK Merck+3.4% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “biotech” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ONCY | +14.34% | +10.68% | base | +10.19% | +15.60% | +12.95% | after close |
| XLV | -2.31% | +0.48% | base | +3.08% | +0.65% | +0.47% | after close |
| XBI | +1.67% | +0.67% | base | +2.69% | -4.21% | -1.76% | after close |
| LLY | -8.42% | +0.54% | base | +0.62% | -2.48% | -3.88% | after close |
| JNJ | +1.93% | +2.66% | base | +3.82% | +2.34% | +3.82% | after close |
| PFE | -1.67% | +1.73% | base | +2.70% | -0.33% | -1.98% | after close |
| MRK | -2.47% | +3.37% | base | +3.94% | +1.84% | +1.45% | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001129928-26-000078 Size: 164 KB Item 8.01: Other Events
Source: sec-edgar
Oncolytics Biotech (ONCY)
Across 4 earlier stories, Oncolytics Biotech (ONCY) the next day averaged +5.83%. The largest gain was +14.96% and the largest drop was -6.28%, from 4 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Oncolytics Biotech (ONCY) | the next day | +5.83% | +14.96% | -6.28% | 4 |
| Oncolytics Biotech (ONCY) | three days later | -0.24% | +5.76% | -9.28% | 4 |
Price since this story was published: Oncolytics Biotech (ONCY)
Since the first closing price after “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer),” Oncolytics Biotech (ONCY) is -2.34%.
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | +3.82% | final price |
| JNJ | the next day | +2.34% | final price |
| JNJ | two days later | +3.82% | final price |
| JNJ | three days earlier | +2.66% | final price |
| JNJ | five days earlier | +1.93% | final price |
| LLY | that day | +0.62% | final price |
| LLY | the next day | -2.48% | final price |
| LLY | two days later | -3.88% | final price |
| LLY | three days earlier | +0.54% | final price |
| LLY | five days earlier | -8.42% | final price |
| MRK | that day | +3.94% | final price |
| MRK | the next day | +1.84% | final price |
| MRK | two days later | +1.45% | final price |
| MRK | three days earlier | +3.37% | final price |
| MRK | five days earlier | -2.47% | final price |
| Oncolytics Biotech (ONCY) | that day | +10.19% | final price |
| Oncolytics Biotech (ONCY) | the next day | +15.60% | final price |
| Oncolytics Biotech (ONCY) | two days later | +12.95% | final price |
| Oncolytics Biotech (ONCY) | three days earlier | +10.68% | final price |
| Oncolytics Biotech (ONCY) | five days earlier | +14.34% | final price |
| PFE | that day | +2.70% | final price |
| PFE | the next day | -0.33% | final price |
| PFE | two days later | -1.98% | final price |
| PFE | three days earlier | +1.73% | final price |
| PFE | five days earlier | -1.67% | final price |
| XBI | that day | +2.69% | final price |
| XBI | the next day | -4.21% | final price |
| XBI | two days later | -1.76% | final price |
| XBI | three days earlier | +0.67% | final price |
| XBI | five days earlier | +1.67% | final price |
| XLV | that day | +3.08% | final price |
| XLV | the next day | +0.65% | final price |
| XLV | two days later | +0.47% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 35 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 57 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 75 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 77 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Oncolytics Biotech (ONCY)
Companies tied to this story
- ONCY Oncolytics Biotech
Oncolytics Biotech (ONCY) is linked, with no stored direction, high confidence in the 4 Nov 2026 story “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ONCY
How “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” reaches Oncolytics Biotech (ONCY)
The 4 Nov 2026 story “8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” names Oncolytics Biotech (ONCY) because of this story.
The link for Oncolytics Biotech (ONCY) is this: SEC 8-K filing -> direct issuer disclosure -> ONCY
Price levels for Oncolytics Biotech (ONCY)
ONCY traded between 0.38 and 0.58 across 19 sessions. The latest close on file is 0.44.
What the saved facts support for Oncolytics Biotech (ONCY)
14 out of 100
“8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.